NeuroPace, Inc.
NPCE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $326 | $267 | $37 | $246 |
| - Cash | $13 | $18 | $7 | $19 |
| + Debt | $73 | $72 | $70 | $50 |
| Enterprise Value | $386 | $321 | $100 | $277 |
| Revenue | $80 | $65 | $46 | $45 |
| % Growth | 22.1% | 43.7% | 0.7% | – |
| Gross Profit | $59 | $48 | $32 | $33 |
| % Margin | 73.9% | 73.6% | 71.4% | 74% |
| EBITDA | -$17 | -$23 | -$37 | -$28 |
| % Margin | -20.7% | -34.9% | -80.3% | -62.8% |
| Net Income | -$27 | -$33 | -$47 | -$36 |
| % Margin | -34% | -50.4% | -103.4% | -79.9% |
| EPS Diluted | -0.93 | -1.27 | -1.91 | -2.17 |
| % Growth | 26.8% | 33.5% | 12% | – |
| Operating Cash Flow | -$18 | -$20 | -$37 | -$25 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$18 | -$20 | -$37 | -$25 |